Gustavo Girotto
3PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 06, 2022
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.Robert I Haddad, Kevin Harrington, Makoto Tahara
|Nov 03, 2021
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.Antoine Adenis, Amit S Kulkarni, Gustavo C Girotto
|Oct 07, 2020
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.Takashi Kojima, Manish A Shah, Kei Muro
Pageof 1
Frequent Collaborators
2 joint publications
Christelle de la Fouchardiere
1 joint publications
Antoine Adenis
1 joint publications
Hanneke W M van Laarhoven
1 joint publications
Wasat Mansoor
1 joint publications
Takashi Kojima
1 joint publications
Manish A Shah
1 joint publications
Toshihiko Doi
1 joint publications
Toshikazu Moriwaki
1 joint publications
Sung-Bae Kim
1 joint publications
Se-Hoon Lee
